Lv2
178 积分 2023-11-06 加入
Efficacy and Pharmacodynamic Modeling of the BTK Inhibitor Evobrutinib in Autoimmune Disease Models
6天前
已完结
Discovery of Zanubrutinib (BGB-3111), a Novel, Potent, and Selective Covalent Inhibitor of Bruton’s Tyrosine Kinase
6天前
已完结
Preclinical characterization of pirtobrutinib, a highly selective, noncovalent (reversible) BTK inhibitor
6天前
已完结
Predictive cytokines of omalizumab in the treatment of chronic spontaneous urticaria
18天前
已完结
C‐reactive protein is linked to disease activity, impact, and response to treatment in patients with chronic spontaneous urticaria
18天前
已完结
Chronic Spontaneous Urticaria and Comorbidities
1个月前
已完结
Remibrutinib in Chronic Spontaneous Urticaria
1个月前
已完结
Intersecting pathways: evaluating inflammatory markers and metabolism in chronic spontaneous urticaria with a multi‐marker approach
1个月前
已完结
Novel TYK2 inhibitor D-2570 in moderate-to-severe plaque psoriasis: A randomized, double-blind, placebo-controlled, phase 2 trial
1个月前
已完结
皖公网安备34019202002308
